You just read:

Biosimilar Cyltezo® demonstrates clinical equivalence to Humira® in patients with moderate-to-severe plaque psoriasis

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Sep 12, 2018, 13:27 ET